1. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study. (16th December 2013) Authors: Fraeman, Kathy H.; Nordstrom, Beth L.; Luo, Weixiu; Landis, Sarah H.; Shantakumar, Sumitra Other Names: Batuman Vecihi Academic Editor. Journal: International journal of hypertension Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Issue 4 (April 2019) Authors: Konstantinopoulos, Panagiotis A; Barry, William T; Birrer, Michael; Westin, Shannon N; Cadoo, Karen A; Shapiro, Geoffrey I; Mayer, Erica L; O'Cearbhaill, Roisin E; Coleman, Robert L; Kochupurakkal, Bose; Whalen, Christin; Curtis, Jennifer; Farooq, Sarah; Luo, Weixiu; Eismann, Julia; Buss, Mary K;... Journal: Lancet oncology Issue: Volume 20:Issue 4(2019) Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Issue 7 (July 2015) Authors: Bernhard, Jürg; Luo, Weixiu; Ribi, Karin; Colleoni, Marco; Burstein, Harold J; Tondini, Carlo; Pinotti, Graziella; Spazzapan, Simon; Ruhstaller, Thomas; Puglisi, Fabio; Pavesi, Lorenzo; Parmar, Vani; Regan, Meredith M; Pagani, Olivia; Fleming, Gini F; Francis, Prudence A; Price, Karen N; Coates, ... Journal: Lancet oncology Issue: Volume 16:Issue 7(2015:Jul.) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial of MK‐2206 in recurrent endometrial cancer. Issue 2 (13th December 2019) Authors: Myers, Andrea P.; Konstantinopoulos, Panagiotis A.; Barry, William T.; Luo, Weixiu; Broaddus, Russell R.; Makker, Vicky; Drapkin, Ronny; Liu, Joyce; Doyle, Austin; Horowitz, Neil S.; Meric‐Bernstam, Funda; Birrer, Michael; Aghajanian, Carol; Coleman, Robert L.; Mills, Gordon B.; Cantley, Lewis C.... Journal: International journal of cancer Issue: Volume 147:Issue 2(2020) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗